I'm curious as to whether Neuren has protected the priority review voucher that would come with an approval of NNZ-2591.
If Acadia was to get the first NNZ-2591 approval - Fragile X through the FDA for example - would they be entitled to the voucher instead of Neuren?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.06 |
Change
0.750(5.63%) |
Mkt cap ! $1.745B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.09 | $12.96 | $5.050M | 368.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 31 | $14.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 1320 | 10 |
View Market Depth
| Last trade - 12.55pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |